Pages that link to "Q48967823"

The following pages link to Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease (Q48967823):

Displaying 28 items.

• Neural restrictive silencer factor and choline acetyltransferase expression in cerebral tissue of Alzheimer's Disease patients: A pilot study (Q24596119) (← links)
• Mild cognitive impairment: pathology and mechanisms. (Q24631255) (← links)
• Toward systems neuroscience in mild cognitive impairment and Alzheimer's disease: a meta-analysis of 75 fMRI studies (Q30870665) (← links)
• Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons (Q33828911) (← links)
• Frontiers in the pathogenesis of Alzheimer's disease (Q34572020) (← links)
• Selective tau tyrosine nitration in non-AD tauopathies (Q35857967) (← links)
• Overview and findings from the religious orders study (Q36130996) (← links)
• X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease (Q36626101) (← links)
• Layer 2/3 synapses in monocular and binocular regions of tree shrew visual cortex express mAChR-dependent long-term depression and long-term potentiation (Q36805118) (← links)
• Differential contributions of subregions of medial temporal lobe to memory system in amnestic mild cognitive impairment: insights from fMRI study (Q36906442) (← links)
• Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme (Q37130148) (← links)
• Neuronal LR11/sorLA expression is reduced in mild cognitive impairment (Q37158949) (← links)
• The neuropathological profile of mild cognitive impairment (MCI): a systematic review. (Q37964897) (← links)
• Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function (Q38209988) (← links)
• Galanin receptors as a potential target for neurological disease. (Q38556483) (← links)
• Cereboost™, an American ginseng extract, improves cognitive function via up-regulation of choline acetyltransferase expression and neuroprotection (Q38775579) (← links)
• Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE (Q41829626) (← links)
• Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation (Q42446739) (← links)
• Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. (Q42489299) (← links)
• Deletion of p75NTR enhances the cholinergic innervation pattern of the visual cortex (Q42507878) (← links)
• Donepezil abolishes anticholinergic activity in a patient with amnesia (Q45789315) (← links)
• Hyperbaric Oxygen Prevents Cognitive Impairments in Mice Induced by D-Galactose by Improving Cholinergic and Anti-apoptotic Functions (Q48000132) (← links)
• White Ginseng Protects Mouse Hippocampal Cells Against Amyloid-Beta Oligomer Toxicity (Q48344833) (← links)
• Enhanced Cognitive Effects of Demethoxycurcumin, a Natural Derivative of Curcumin on Scopolamine-Induced Memory Impairment in Mice. (Q50492452) (← links)
• Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease (Q51154144) (← links)
• Royal Jelly Ameliorates Behavioral Deficits, Cholinergic System Deficiency, and Autonomic Nervous Dysfunction in Ovariectomized Cholesterol-Fed Rabbits (Q64063020) (← links)
• Panax ginseng components and the pathogenesis of Alzheimer's disease (Review) (Q64269770) (← links)
• Relationship of Wine Consumption with Alzheimer's Disease (Q92663689) (← links)